Aung Sammy San Myint, Latt Htun, Kyaw Kyaw, Roongsritong Chanwit
Institute for Heart and Vascular Health, Renown Regional Medical Center, 1500 E 2nd St No. 302, Reno, NV 89502, USA.
Department of Internal Medicine, School of Medicine, University of Nevada-Reno, 1155 Mill St No. W11, Reno, NV 89502, USA.
Case Rep Cardiol. 2018 Jun 4;2018:4579184. doi: 10.1155/2018/4579184. eCollection 2018.
Coronary interventions are the mainstay of treatment for stenotic coronary vascular lesions. New stent designs are constantly being evaluated to improve stent performances and clinical outcomes. Coronary stent fracture is uncommon; however, it is associated with potential major consequences including acute coronary syndrome and the need for repeated target vessel revascularization due to in-stent restenosis or stent thrombosis. We report a case of a 66-year-old man with an extensive cardiac disease history, who presented with intractable angina and was found to have a fracture of a current generation, platinum chromium everolimus-eluting stent (Synergy, Boston Scientific Inc.).
冠状动脉介入治疗是狭窄性冠状动脉血管病变的主要治疗手段。新型支架设计不断得到评估，以改善支架性能和临床疗效。冠状动脉支架断裂并不常见；然而，它与包括急性冠状动脉综合征以及因支架内再狭窄或支架血栓形成而需要重复进行靶血管血运重建等潜在的严重后果相关。我们报告一例66岁男性患者，其有广泛心脏病史，因顽固性心绞痛就诊，经检查发现其植入的新一代铂铬依维莫司洗脱支架（Synergy，波士顿科学公司）发生断裂。
